Learn about EGFR Test Treatment in Turkey — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in EGFR Test and request assistance for cost estimates or appointments.

About EGFR Test

An EGFR (Epidermal Growth Factor Receptor) test is a specialized molecular diagnostic procedure performed by a pathologist to analyze tumor tissue. This test detects mutations in the EGFR gene, which are commonly found in certain cancers, most notably non-small cell lung cancer (NSCLC). The procedure involves extracting DNA from a patient's tumor biopsy or surgical specimen and using advanced laboratory techniques like polymerase chain reaction (PCR) or next-generation sequencing (NGS) to identify specific genetic alterations. The results are critical for guiding targeted therapy, as they determine a patient's eligibility for EGFR tyrosine kinase inhibitor drugs, which can block the signals that promote cancer growth. This personalized approach helps oncologists select the most effective treatment, improving outcomes and potentially reducing exposure to less effective therapies.

Key Highlights

    Enables personalized, targeted cancer therapy based on genetic profile.Helps identify patients most likely to respond to specific, effective EGFR inhibitor drugs.Can improve treatment outcomes and potentially extend survival for eligible patients.Minimizes exposure to less effective or more toxic chemotherapy regimens.Performed on existing tissue samples (biopsy or surgical specimen), often requiring no additional procedure for the patient.Provides critical information for treatment planning and prognosis./ul

Who is this surgery for?

  • Diagnosis of non-small cell lung cancer (NSCLC), particularly adenocarcinoma subtype.
  • Planning initial systemic therapy for advanced or metastatic NSCLC.
  • Evaluation when a patient with NSCLC experiences progression after first-line treatment.
  • Diagnosis of other cancers where EGFR mutations may be relevant, such as glioblastoma or certain head and neck cancers (less common).
  • As part of comprehensive molecular profiling for cancer.

How to prepare

  • The test is performed on a tissue sample already obtained via biopsy or surgery; no new preparation is needed from the patient for the test itself.
  • Patients should ensure their oncologist and pathologist have access to the tumor tissue block or slides.
  • Informed consent for molecular testing is typically part of the broader consent for cancer diagnosis and treatment.
  • No fasting, medication changes, or physical preparation is required for the laboratory analysis.

Risks & possible complications

  • The primary risk is associated with the initial biopsy or surgery to obtain the tissue sample, not the lab test itself.
  • Potential for insufficient or degraded tumor tissue in the sample, leading to an inconclusive result.
  • False-negative or false-positive results are possible but minimized by accredited laboratory protocols.
  • Delay in treatment decisions if sample processing or testing is delayed.
  • Psychological impact of waiting for genetic test results.

Recovery & hospital stay

  • There is no physical recovery needed from the EGFR test itself, as it is a laboratory analysis.
  • Recovery pertains to the prior procedure (biopsy or surgery) used to obtain the tissue sample.
  • Patients should follow up with their oncologist to discuss the test results and subsequent treatment plan.
  • No specific activity restrictions or wound care is related to the laboratory testing process.
  • checked Typical hospital stay: 0 days (outpatient lab test)
  • checked Expected recovery time: 0 days (for the test itself)

Frequently Asked Questions

If you are considering egfr test in Turkey, these questions and answers can help you make a confident, informed decision.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for egfr test compare across other countries where we have data.

Country Estimated cost range Typical stay Recovery time View details
India USD 88 – USD 275 0 days (outpatient lab test) ~ 0 days (for the test itself) Know More
Turkey USD 656 – USD 2,049 0 days (outpatient lab test) ~ 0 days (for the test itself) Know More
PATIENT REVIEW

Aditya Khan, a 45-year-old software developer...

Aditya Khan, a 45-year-old software developer and father of two young children, was the picture of health until he developed a nagging pain in his hip. Scans revealed it was a metastasis; the primary cancer was in his lungs. As a never-smoker, the diagnosis was a devastating shock. His oncologist immediately ordered an EGFR test on his biopsy sample, explaining that in young, non-smoking patients with lung adenocarcinoma, such mutations are common and highly treatable. The wait for the pathology report was a terrifying limbo, overshadowing the physical pain. When his doctor called with the news that his cancer was driven by an EGFR mutation, Aditya wept with relief. He began a targeted therapy, which controlled his disease effectively for years. While he faces the reality of a chronic illness, the test result transformed his prognosis from a statistical nightmare to a manageable condition. It gave him back his future, the chance to watch his children grow up, and turned his fear into a determined focus on living well.